Extended panels (on request)

PD-L1 (CD274) mRNA

Solid tumours, supplementary marker

Clinical area
Extended panels (on request)
Method
mRNA expression (RT-qPCR)
Sample
FFPE tissue block
Report languages
EN · AR · RU

About this test

Quantifies CD274 (PD-L1) mRNA expression in tumour tissue by RT-qPCR. Eligibility for immunotherapy is defined by validated PD-L1 immunohistochemistry assays; this test is a supplementary result and does not replace them.

When to order

As an additional data point for research or case review when requested by the oncologist or pathologist.

Available assays

  • PD-L1 expression analysis kitmRNA expression (RT-qPCR)

Offered on request. Current guidelines give this test a limited role in routine practice; results are reported as genotype or expression data for the ordering clinician to interpret.

Results are reported to the ordering physician and should be interpreted in clinical context.

Request this test

Offer this test to your patients.

Contract pricing and turnaround times are provided on request for laboratories and clinics.